CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
7,365,418
Share change
-4,267,551
Total reported value
$11,783,000
Price per share
$1.60
Number of holders
20
Value change
-$16,734,941
Number of buys
14
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q1 2017

As of 31 Mar 2017, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,365,418 shares. The largest 10 holders included SV Health Investors, LLC, Clarus Ventures, LLC, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, Rhenman & Partners Asset Management AB, Alyeska Investment Group, L.P., BRIDGEWAY CAPITAL MANAGEMENT INC, OPPENHEIMER & CO INC, RENAISSANCE TECHNOLOGIES LLC, and A.R.T. Advisors, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.